A 52-year-old woman from Chennai presents with a thyroid nodule. Fine-needle aspiration cytology shows follicular cells with increased mitotic figures and marked nuclear enlargement. Histopathology reveals widespread vascular invasion and extrathyroidal extension. Which single feature most reliably distinguishes this tumor from papillary thyroid carcinoma?

Explanation

## Diagnostic Distinction: FTC vs PTC in a Clinically Aggressive Presentation ### Clinical Context This patient has a thyroid tumor with aggressive features (vascular invasion, extrathyroidal extension, high mitotic rate). While both PTC and FTC can present with advanced disease, the **diagnostic criterion** that separates them is independent of clinical aggressiveness. ### The Defining Criterion for FTC **Key Point:** Follicular thyroid carcinoma is defined by the **presence of vascular invasion** (and/or capsular invasion) **in a tumor with normal nuclear morphology**. This is a histopathological definition, not a clinical one. **High-Yield:** PTC is defined by nuclear features (grooves, pseudoinclusions, pale chromatin) regardless of whether vascular invasion is present. FTC is defined by vascular/capsular invasion in the absence of PTC-type nuclear features. ### Comparison: Diagnostic Criteria | Criterion | PTC | FTC | |-----------|-----|-----| | **Nuclear grooves** | Required for diagnosis | NOT present | | **Pseudoinclusions** | Characteristic | Absent | | **Vascular invasion** | Not required; may be absent | Required for diagnosis | | **Capsular invasion** | Not required | May be present (with vascular invasion) | | **Normal nuclei** | No (nuclei are abnormal) | Yes (nuclei are normal) | | **Extrathyroidal extension** | Can occur in aggressive cases | Can occur in aggressive cases | ### Why This Case Is FTC The vignette describes a tumor with: - Follicular cells (not papillary architecture) - **Normal nuclear morphology** (no mention of grooves or pseudoinclusions) - **Vascular invasion** (explicitly stated) - Extrathyroidal extension (advanced disease) The combination of vascular invasion + normal nuclei = FTC, regardless of clinical aggressiveness. ### Clinical Pearl **Warning:** Do not confuse clinical aggressiveness with histopathological diagnosis. A PTC can be aggressive (with extrathyroidal extension and lymph node metastases). An FTC can be indolent. The diagnosis depends on morphology, not behavior. However, FTC has a higher propensity for **hematogenous spread** (bone, lung, brain), whereas PTC typically spreads to **lymph nodes** first. [cite:Robbins 10e Ch 24]